Arphra
live
S&P 5000.31
NASDAQ0.00
DOW49,602.49
VIX18.06
US10Y4.47
EUR/USD1.1530
GOLD4,349.3
WTI91.36
BTC63,064.99
S&P 5000.31
NASDAQ0.00
DOW49,602.49
VIX18.06
US10Y4.47
EUR/USD1.1530
GOLD4,349.3
WTI91.36
BTC63,064.99

UTRS

Minerva Surgical, Inc.
HealthcareMedical - Healthcare Information ServicesUSUSDPeers →via fmp_bulk
$0.00
LiveJun 05, 2026
AI Brief
Market cap
$888
52w range
0.00 – 0.00
P / E
EPS
Volume
500
Revenue · FY

Explain this page

Arphra AI
Business description
· company · SEC profile

Minerva Surgical, Inc.

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Founded
IPO
Oct 22, 2021
Employees
174
HQ
Santa Clara, CA
CEO
Darin Hammers
CFO
Exchange
OTC
Fiscal year
Identifiers
· company_identifiers
CIK0001452965
CUSIP60343F106
ISINUS60343F2056
FIGI
LEI